Compare ICG & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICG | SERA |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.4M | 75.2M |
| IPO Year | 2022 | 2021 |
| Metric | ICG | SERA |
|---|---|---|
| Price | $1.42 | $2.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $2.00 | ★ $5.50 |
| AVG Volume (30 Days) | ★ 286.3K | 11.4K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $81,000.00 |
| Revenue This Year | N/A | $177.78 |
| Revenue Next Year | $109.44 | $755.56 |
| P/E Ratio | $6.80 | ★ N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $0.60 | $1.56 |
| 52 Week High | $2.28 | $3.94 |
| Indicator | ICG | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 70.03 | 54.02 |
| Support Level | $1.41 | $2.00 |
| Resistance Level | $2.22 | $2.21 |
| Average True Range (ATR) | 0.15 | 0.06 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 84.07 | 35.00 |
Intchains Group Ltd is an inventive altcoins development company that engages in the provision of altcoin mining products, the strategic acquisition and holding of Ethereum-based cryptocurrencies and the active development of inventive Web3 applications. The company offers high-performance mining products including altcoin mining machines incorporating its ASIC chips that have high computing power and superior power efficiency, ASIC chips and ancillary software and hardware, all of which cater to the evolving needs of the blockchain industry. Geographically, it operates in Mainland China, Hong Kong, and Other countries or regions.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.